In a move aimed at strengthening governance, Gujarat Kidney and Super Speciality Limited announced that its board has appointed Paresh Dhoti as an Additional Non-Executive Independent Director, effective 9 July 2026. The appointment, not liable to retire by rotation, will run for a first five-year term and is subject to approval by shareholders at the next Annual General Meeting. The decision reflects a continuing emphasis on independent oversight as the company charts its next phase of growth.
Dhoti, who earned a Bachelor of Dentistry in 2006 from Government Medical College, Ahmedabad, has practiced independently in Vadodara for about 18 years. The company notes that he is not related to any director, and the appointment comes on the recommendation of the Nomination and Remuneration Committee. His background adds to the board’s diversity of professional expertise and local healthcare insight as Gujarat Kidney pursues governance best practices.
Independent directors like Dhoti are increasingly seen as pivotal in providing objective oversight as the company expands beyond its traditional footprint. The move signals a governance-forward approach aligning with the board’s broader strategy to strengthen leadership depth. In the same board discussions, Gujarat Kidney also explored strategic steps to expand its geographic and service reach, including a plan to acquire a 51% stake in Blue Tree Clinics LLC, UAE, for a total consideration of Rs 19,83,64,500 to be paid in two tranches, with completion targeted within 50 days.